‹ All Posts
TrueNorth Capital

5th Apr · SEBI-Registered Analyst

- ECMS Approvals Boost Domestic Component Manufacturing

On 30 March 2026, the Ministry of Electronics and IT (MeitY) approved 29 new proposals under the Electronics Component Manufacturing Scheme (ECMS), marking a significant step in India’s localization drive. With investments of ₹7,104 crore expected to generate production worth ₹84,515 crore, the approvals span critical areas such as tantalum capacitors, flexible PCBs, and rare earth permanent magnets. For listed EMS firms like Dixon Technologies and Syrma SGS Technology, the approvals represent structural opportunities to move beyond assembly into higher-value component manufacturing. Company Highlights -

DIXON
- JV with HKC approved for display module manufacturing; trials from Q2FY27, ramp-up in H2FY27. - Initial capacity: ~24 million smartphone and 2 million laptop displays; scalable to ~55 million units. - Scaling camera module output from ~8 million units/month to ~100 million annually. - Stock corrected ~50% from Sep 2025 peak; near-term overhang from memory chip shortage impacting assembly volumes. - Risk-reward now more favorable; stance upgraded to Equal-Weight. -
SYRMA
- ECMS approvals across PCB value chain: copper clad laminates, HDI boards, flexible circuits. - Construction underway; trial production expected late 2026/early 2027. - Positioned as a key beneficiary of localization theme. - Execution critical over next 2–4 years; stance maintained at Over-Weight. Sector Context & Outlook - ECMS approvals strengthen India’s electronics ecosystem, reducing import dependence. - Investments span laminates, relays, capital goods, and rare earth magnets, supporting broader supply chain resilience. - For investors, ECMS is a long-term structural opportunity, with meaningful earnings contributions expected only over the next 2–4 years. - Any further correction in Dixon or Syrma could provide accumulation opportunities for medium- to long-term horizons.

#WatchOutFor
919 likes·78 comments